A fireside chat with Dr. Weickert, CEO Pacylex - an early-stage startup in life sciences. Pacylex Pharmaceuticals, Inc. is developing a precision medicine solution for multiple common cancers. The work that Pacylex is doing is ground-breaking and because of that Dr. Weickert was recently named a CEO to watch by CIOViews, having just closed a Series A funding round and which will allow Pacylex to begin its first clinical study (press release)

With 29 years of experience in the biotech, medical device, pharmaceutical and drug delivery industries, Dr. Michael J. Weickert brings together thought leaders, strategic partners, and investors to develop and market trailblazing products that might otherwise go unnoticed. He has provided international executive leadership for both established and start-up companies. Dr. Weickert has written scores of business plans and the presentations that accompany them, and is an accomplished speaker who has presented at more than 60 national and international meetings, and has won top honors in judged competitions while presenting company stories to investors.

Join Startup Grind Kansas City to learn what it takes to go from business plan to execution, securing funding along the way and knowing when you have a 'Diamond in the rough'.